In the T-ALL cases of PTEN deletion, despite NOTCH1–HES1 inhibition, the PI3K–AKT signaling will be maintained in an active tone, impairing full response to NOTCH1 inhibition, thus accounting for one potential intrinsic resistance mechanism to GSI treatment (80). This evidence concerns the gene PTEN and acute lymphoblastic leukemia.